According to Taro Pharmaceutical's latest financial reports the company's current EPS (TTM) is 0,57ย โฌ. In 2021 the company made an earnings per share (EPS) of 0,03730ย โฌ an increase over its 2020 EPS that were of -7,38ย โฌ.